Jove
Visualize
Contact Us

Related Experiment Videos

Exempt preparations: Historical perspectives.

Louis S Harris1

  • 1Department of Pharmacology and Toxicology, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA. harris@vcu.edu

Drug and Alcohol Dependence
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys.

International journal of medicinal chemistry·2015
Same author

Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor.

Molecular pain·2014
Same author

Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects.

Journal of medicinal chemistry·2012
Same author

l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice.

Pharmacology, biochemistry, and behavior·2012
Same author

Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice.

Pharmacology, biochemistry, and behavior·2009
Same author

Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines.

Journal of medicinal chemistry·2009
Same journal

Impact of medicaid waivers on medication for opioid use disorders in residential facilities: Evidence from twenty-five states.

Drug and alcohol dependence·2026
Same journal

Mental and somatic multimorbidity among individuals with alcohol use disorder: A sex-stratified registry study.

Drug and alcohol dependence·2026
Same journal

Monitoring novel psychoactive substance trends on social media: Analysis of discussions and dashboard implementation.

Drug and alcohol dependence·2026
Same journal

A meta-analysis on the relationship between cultural identity and substance use among indigenous youth.

Drug and alcohol dependence·2026
Same journal

Examining heterogeneity in pathways between alcohol-related factors and drinking during topiramate pharmacotherapy: A person-specific analysis.

Drug and alcohol dependence·2026
Same journal

The impact of severe mental illness on treatment retention and all-cause mortality among people in opioid agonist treatment.

Drug and alcohol dependence·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

This article reviews the history and use of "exempt preparations," which are medications formulated to reduce abuse liability. This concept allows useful therapeutic agents to have reduced regulatory control.

Area of Science:

  • Pharmacology
  • Drug Policy
  • Medicinal Chemistry

Background:

  • Medication formulation significantly impacts abuse liability.
  • The concept of "exempt preparations" has evolved internationally.
  • Regulatory control over medications is crucial for public health.

Observation:

  • The history of "exempt preparations" spans from international origins to current national and international applications.
  • Key organizations like the World Health Organization Expert Committee on Drug Dependence (ECDD) and the College on Problems of Drug Dependence (CDPP) have played roles in this development.
  • Specific examples of exempt preparations illustrate the practical application of this concept.

Findings:

  • The concept of exempt preparations has a well-documented history of international and national development.

Related Experiment Videos

  • The World Health Organization Expert Committee on Drug Dependence (ECDD) and the College on Problems of Drug Dependence (CDPP) have been instrumental in shaping its use.
  • Exempt preparations serve as a mechanism to balance therapeutic utility with the need for regulatory oversight.

    • Implications:

    • The "exempt preparations" concept facilitates the marketing of valuable therapeutic agents with diminished regulatory burdens.
    • Understanding the history and application of exempt preparations is vital for drug policy and pharmaceutical regulation.
    • This approach allows for wider access to beneficial medications while mitigating potential abuse risks.